In lieu of a Super Bowl ad this year, Pfizer has unveiled a year-long cancer campaign that aims to encourage screening.
To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time. | To stir ...
Pfizer's experimental obesity drug, acquired through Metsera, shows promise, reporting up to 12.3% weight loss in a 28-week trial. Targeting regulatory approval by 2028, Pfizer plans over 20 clinical ...
Pfizer's oncology ambitions could start to take shape next year. The drugmaker is also likely to make progress in the weight-loss market. It might take a while longer, but Pfizer is on the path to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results